Maze Therapeutics, Inc.MAZE
Price (close)
$26.21
Market cap
$1.5B
P/E
—
Revenue (TTM)
—
Net income
-$133.6M
Dividend yield
—
1-year total return
-0.5%
Net margin
—
Revenue growth
—
Debt / equity
0.09x
What Maze Therapeutics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | — | $167.5M | — |
| Net income | — | $52.2M | -$131.1M |
| Free cash flow | — | $74.8M | -$112.7M |
More on MAZE.
- Maze Therapeutics, Inc. summary
- Maze Therapeutics, Inc. financial statements
- Maze Therapeutics, Inc. key metrics
- Maze Therapeutics, Inc. health scores and style box
- Maze Therapeutics, Inc. earnings
- Maze Therapeutics, Inc. dividends
- Maze Therapeutics, Inc. valuation
- Maze Therapeutics, Inc. ownership and insiders
- Maze Therapeutics, Inc. peers
Figures from Maze Therapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.